155 related articles for article (PubMed ID: 8552575)
1. Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms.
Jimenez FJ; Burchette JL; Grichnik JM; Hitchcock MG
Mod Pathol; 1995 Oct; 8(8):854-8. PubMed ID: 8552575
[TBL] [Abstract][Full Text] [Related]
2. Ber-EP4 antigen is a marker for a cell population related to the secondary hair germ.
Ozawa M; Aiba S; Kurosawa M; Tagami H
Exp Dermatol; 2004 Jul; 13(7):401-5. PubMed ID: 15217359
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
4. Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms.
Ansai S; Takayama R; Kimura T; Kawana S
J Dermatol; 2012 Aug; 39(8):688-92. PubMed ID: 22300237
[TBL] [Abstract][Full Text] [Related]
5. Anti-human epithelial antigen (Ber-EP4) helps define basal cell carcinoma masked by inflammation.
Kist D; Perkins W; Christ S; Zachary CB
Dermatol Surg; 1997 Nov; 23(11):1067-70. PubMed ID: 9391566
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of calretinin in normal hair follicles and tumors with follicular differentiation].
González-Guerra E; Requena L; Kutzner H
Actas Dermosifiliogr; 2008; 99(6):456-63. PubMed ID: 18558053
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin.
Tellechea O; Reis JP; Domingues JC; Baptista AP
Am J Dermatopathol; 1993 Oct; 15(5):452-5. PubMed ID: 8238781
[TBL] [Abstract][Full Text] [Related]
8. [Contribution of monoclonal antibody D 47 in the study of sweat gland pathology].
Kanitakis J; Schmitt D; Thivolet J
Ann Pathol; 1985; 5(1):19-27. PubMed ID: 2990499
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations.
González-Guerra E; Kutzner H; Rutten A; Requena L
Am J Dermatopathol; 2012 Jul; 34(5):491-505. PubMed ID: 22343111
[TBL] [Abstract][Full Text] [Related]
10. Limitations of Ber-EP4 for distinction of Bowen disease from basal cell carcinoma.
Kogut M; Toberer F; Enk AH; Hassel JC
J Cutan Pathol; 2016 Apr; 43(4):367-71. PubMed ID: 26765054
[TBL] [Abstract][Full Text] [Related]
11. Utility of Ber-EP4 and MOC-31 in Basaloid Skin Tumor Detection.
Gill P; Naugler C; Abi Daoud MS
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):584-588. PubMed ID: 29629953
[TBL] [Abstract][Full Text] [Related]
12. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
13. Ber-EP4 enhances the differential diagnostic accuracy of cytokeratin 7 in pagetoid cutaneous neoplasms.
Sellheyer K; Krahl D
J Cutan Pathol; 2008 Apr; 35(4):366-72. PubMed ID: 18333896
[TBL] [Abstract][Full Text] [Related]
14. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry in ocular carcinomas.
Sramek B; Lisle A; Loy T
J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
[TBL] [Abstract][Full Text] [Related]
16. Divergent differentiation in endocrine and nonendocrine tumors of the skin.
Foschini MP; Eusebi V
Semin Diagn Pathol; 2000 May; 17(2):162-8. PubMed ID: 10839616
[TBL] [Abstract][Full Text] [Related]
17. Tubular adenoma of the skin with follicular and sebaceous differentiation: A report of two cases.
Kazakov DV; Mukensnabl P; Michal M
Am J Dermatopathol; 2006 Apr; 28(2):142-6. PubMed ID: 16625077
[TBL] [Abstract][Full Text] [Related]
18. Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery.
Katz KH; Helm KF; Billingsley EM; Maloney ME
J Am Acad Dermatol; 2001 Aug; 45(2):231-8. PubMed ID: 11464184
[TBL] [Abstract][Full Text] [Related]
19. Distribution of epithelial membrane antigen in eccrine poroma.
Takanashi M; Urabe A; Nakayama J; Hori Y
Dermatologica; 1991; 183(3):187-90. PubMed ID: 1720746
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical differentiation of basal cell epithelioma from cutaneous appendages using monoclonal anti-glycoprotein antibody TNKH1. Its application in Mohs' micrographic surgery.
Setoyama M; Hashimoto K; Dinehart SM; Choi KC; Ishihara M; Predeteanu GS; Tronnier M; Pietruk T; Nakanishi T
Cancer; 1990 Dec; 66(12):2533-40. PubMed ID: 2249196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
